Search results

Jump to: navigation, search

Page title matches

  • ...oston.fbi.gov/dojpressrel/pressrel07/drugmarketing092807.htm BRISTOL-MYERS SQUIBB TO PAY MORE THAN $515 MILLION TO RESOLVE ALLEGATIONS OF ILLEGAL DRUG MARKET ...drugs for 'off label' purposes. As part of the settlement, Bristol-Myers Squibb entered into a Corporate Integrity Agreement with the Office of Inspector G
    21 KB (2,852 words) - 14:40, 29 January 2015
  • ...oston.fbi.gov/dojpressrel/pressrel07/drugmarketing092807.htm BRISTOL-MYERS SQUIBB TO PAY MORE THAN $515 MILLION TO RESOLVE ALLEGATIONS OF ILLEGAL DRUG MARKET ...drugs for 'off label' purposes. As part of the settlement, Bristol-Myers Squibb entered into a Corporate Integrity Agreement with the Office of Inspector G
    5 KB (731 words) - 14:51, 20 December 2007
  • #REDIRECT [[Bristol-Myers Squibb: Illegal Activities]]
    54 bytes (5 words) - 12:25, 20 December 2007

Page text matches

  • ...nts include Dow Chemical, the Aspirin Foundation of America, Bristol Myers Squibb, and the National Pharmaceutical Council.<ref>Martin Donohoe, "[http://phsj
    8 KB (1,072 words) - 09:33, 8 April 2015
  • ...) and non-executive chairman of the Board of Directors for [[Bristol-Myers Squibb]] (since 1976). He also serves on the Boards of Directors of [[Novell Inc.]
    32 KB (4,534 words) - 14:23, 12 July 2016
  • '''Collaborations:''' [[Abbott]], [[ARIAD]], [[BASF]], Bayer, [[Bristol-Myers Squibb]], [[Eli Lilly]], [[Genetech]], [[Hoechst]], [[Hoffmann La-Roche]], [[Johns ...partners include [[Pharmacia]] (about 40% of revenues) and [[Bristol-Myers Squibb]].{{ref|124}}
    50 KB (7,192 words) - 20:24, 3 June 2013
  • ...) and non-executive chairman of the Board of Directors for [[Bristol-Myers Squibb]] (since 1976). He also serves on the Boards of Directors of [[Novell Inc.]
    33 KB (4,955 words) - 07:16, 19 February 2011
  • ...n the Senate lobbying records for 2003 included Biogen, Inc, Bristol-Myers Squibb, Glaxo Smith Kline, Petroleum Marketers Assn of America, Phrma and NewsCorp
    16 KB (2,237 words) - 09:40, 14 October 2016
  • ...ce | [[Biogen]] Idec MA Inc. | Boehringer Ingelheim GmbH | [[Bristol-Myers Squibb]] Company | Charles River Laboratories | Covance Laboratories, Inc. | Daiic
    27 KB (3,759 words) - 09:52, 31 August 2015
  • ...) and non-executive chairman of the Board of Directors for [[Bristol-Myers Squibb]] (since 1976). His biography goes on to report that he also serves on the
    7 KB (980 words) - 11:16, 10 February 2008
  • ...) and non-executive chairman of the Board of Directors for [[Bristol-Myers Squibb]] (since 1976). He also serves on the Boards of Directors of [[Novell Inc.]
    3 KB (452 words) - 22:10, 21 December 2017
  • *[[BMS (Bristol-Myers Squibb)]]
    5 KB (560 words) - 19:19, 14 April 2006
  • *Bristol Myers Squibb
    3 KB (328 words) - 12:32, 31 May 2007
  • ...man-Hillard]], is now policy and public affairs manager at [[Bristol-Myers Squibb]]<ref> [https://uk.linkedin.com/pub/richard-robinson/26/902/554 Richard Rob
    37 KB (4,488 words) - 08:44, 25 July 2016
  • *[[Bristol-Myers Squibb]]
    17 KB (2,257 words) - 15:22, 5 May 2016
  • [[Bayer]] | [[Boehringer Ingelheim]] | [[Bristol-Myers Squibb]] | [[GlaxoSmithKline]] | [[Ortho-Biotech]] | [[Merck]] | [[Novartis]] | [[
    3 KB (277 words) - 16:39, 22 October 2014
  • ...lton]], [[Burson Marsteller]], [[Rockwell International]], [[Bristol-Myers Squibb]], [[General Motors]] and [[Nippon Telephone and Telegraph]]. A cooperative
    16 KB (2,361 words) - 14:01, 8 February 2007
  • ...Vice President & President, Worldwide Pharmaceuticals for [[Bristol-Myers Squibb]] * [[Bristol-Myers Squibb]]
    17 KB (2,252 words) - 21:22, 6 December 2010
  • *[[Bristol-Myers Squibb Company]]
    12 KB (1,740 words) - 17:41, 28 March 2008
  • ...petitors are [[Merck]], [[GlaxoSmithKline]], [[Novartis]], [[Bristol Myers Squibb]] and [[AstraZeneca]].
    24 KB (3,261 words) - 14:30, 13 July 2016
  • * [[Bristol-Myers Squibb]] Company
    853 bytes (94 words) - 19:19, 9 January 2008
  • *[[Bristol Myers Squibb]]
    3 KB (288 words) - 07:47, 18 June 2008
  • Bristol Myers Squibb Company Pharmaceutical US
    6 KB (764 words) - 12:37, 9 May 2008
  • ...="tablelist10">UK</td></tr><tr><td class=“tablelist10”>[[Bristol Myers Squibb Company]]</td><td class="tablelist10">Pharmaceutical</td><td class="tableli
    24 KB (3,366 words) - 10:14, 7 October 2015
  • ...cations. His clients have included Gillette, Kellogg, Merck, Bristol-Myers Squibb, Mercedes-Benz, IBM, Nestle and Johnson & Johnson. Prior to joining Ogilvy
    8 KB (1,224 words) - 22:02, 2 December 2006
  • Paul has worked companies such as, [[Bristol-Myers Squibb]], [[Cigna]], [[Centocor]], [[Hoffman-LaRoche]], [[Merck]], Ortho Biotech a
    11 KB (1,624 words) - 18:47, 23 March 2007
  • ...lton]], [[Burson Marsteller]], [[Rockwell International]], [[Bristol-Myers Squibb]], [[General Motors]] and [[Nippon Telephone and Telegraph]]. *[[Bristol-Myers Squibb Company]]
    5 KB (653 words) - 08:54, 7 March 2007
  • ...ont announced it would sell its pharmaceutical business to [[Bristol Myers Squibb]]. {{ref|31}} The company continued to 'streamline' its workforce, shedding
    22 KB (3,184 words) - 14:36, 12 July 2016
  • ...rmaceutical companies examined in the report (Merck, Pfizer, Bristol-Myers Squibb, Pharmacia, Abbott Laboratories, American Home Products, Eli Lilly, Scherin ...amount of unexercised stock options was C.A. Heimbold, Jr., Bristol-Myers Squibb's Chairman and CEO, who held $227.9 million (£155,4 million) in unexercise
    51 KB (7,869 words) - 21:25, 18 February 2007
  • ...a scientific front group that also receives donations from [[Bristol-Myers Squibb]], [[Johnson & Johnson]], [[Procter & Gamble Pharmaceutical]] and [[SmithKl
    75 KB (11,176 words) - 11:18, 24 August 2009
  • :Chairman and Chief Executive Officer, [[Bristol-Myers Squibb]] Company (manufacturer of consumer products and pharmaceuticals)
    20 KB (2,685 words) - 16:47, 27 July 2007
  • ...) and non-executive chairman of the Board of Directors for [[Bristol-Myers Squibb]] (since 1976). He also serves on the Boards of Directors of [[Novell Inc.]
    11 KB (1,608 words) - 13:44, 20 September 2010
  • [[Bristol-Myers Squibb]] | [[Melanoma UK]] <ref>[https://registerofconsultantlobbyists.force.com/C [[Bristol-Myers Squibb]] | [[Hospira]] | [[Janssen]]
    21 KB (2,498 words) - 20:22, 11 September 2017
  • ...er Property Management]] | [[Bmor]] | [[Bourne Capital]] | [[Bristol-Myers Squibb]] | [[British Land]] | [[Camden Town Unlimited]] | [[Can Mezzanine]] | [[Ca ...[Bhuchar Rock (ealing) Ltd.]] | [[Bougyues]] | [[BRE/Hemel 1 Limited]] | [[Bristol Port Company]] | [[British Waterways]] | [[Brockton Capital]] | [[English C
    39 KB (4,248 words) - 10:27, 7 March 2018
  • ...merican Ambassadors: He is at present a senior consultant to Bristol-Myers Squibb Company. Gelb had been appointed Commissioner for the United Nations, Consu ...to his service in government, he was Vice Chairman of the Board of Bristol-Myers Company. Bruce Gelb has served as a member of President Bush’s Arts and H
    14 KB (2,187 words) - 20:37, 17 September 2008
  • Bristol-Myers Squibb
    2 KB (265 words) - 00:30, 6 March 2012
  • '''Pharmaceuticals & biotechnology:''' [[Biogen Idec]], [[Bristol-Myers-Squibb]], [[Genzyme]], [[GlaxoSmithKline]], [[Johnson & Johnson]], [[Merck & Co.]]
    28 KB (3,810 words) - 12:15, 21 January 2020
  • ...Center’s executive board also include representatives from Bristol-Myers Squibb; Coca-Cola; and Wal-Mart Stores Inc.[73]
    13 KB (1,776 words) - 18:07, 29 July 2007
  • <td>[[Bristol-Myers Squibb]] Company</td>
    20 KB (2,888 words) - 13:20, 24 October 2014
  • ...Illness Advocacy Networks was founded by the drug company [[Bristol Myers Squibb]] in March 1997, bringing together 12 organisations including [[Depression
    982 bytes (126 words) - 08:00, 22 October 2007
  • Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership The U.S. Department of Justice announced in May 2007 that [[Bristol-Myers Squibb Company]] (BMS) had agreed to plead guilty on two violations of the federal
    16 KB (2,212 words) - 15:53, 5 November 2014
  • • [[AstraZeneca / Bristol-Myers Squibb Alliance in Diabetes]] • [[Bristol-Myers Squibb Virology]]
    8 KB (1,037 words) - 03:21, 18 February 2015
  • ...oston.fbi.gov/dojpressrel/pressrel07/drugmarketing092807.htm BRISTOL-MYERS SQUIBB TO PAY MORE THAN $515 MILLION TO RESOLVE ALLEGATIONS OF ILLEGAL DRUG MARKET ...drugs for 'off label' purposes. As part of the settlement, Bristol-Myers Squibb entered into a Corporate Integrity Agreement with the Office of Inspector G
    21 KB (2,852 words) - 14:40, 29 January 2015
  • ...oston.fbi.gov/dojpressrel/pressrel07/drugmarketing092807.htm BRISTOL-MYERS SQUIBB TO PAY MORE THAN $515 MILLION TO RESOLVE ALLEGATIONS OF ILLEGAL DRUG MARKET ...drugs for 'off label' purposes. As part of the settlement, Bristol-Myers Squibb entered into a Corporate Integrity Agreement with the Office of Inspector G
    5 KB (731 words) - 14:51, 20 December 2007
  • #REDIRECT [[Bristol-Myers Squibb: Illegal Activities]]
    54 bytes (5 words) - 12:25, 20 December 2007
  • ...eneca]], [[Bayer Pharmaceuticals]], [[Bayer Diagnostics]], [[Bristol-Myers Squibb]], [[Eli Lilly]], [[GlaxoSmithKline]], [[Merck]], [[Novartis]], [[Pfizer]], In 2005 EMHF's main sponsors were [[Bristol-Myers Squibb]], [[Eli Lilly]], [[GlaxoSmithKline]], [[Novartis]] and [[Pfizer]]<ref>ibid
    9 KB (1,198 words) - 19:41, 20 November 2008
  • ...ents include 15 years service in management positions with [[Bristol-Myers Squibb Company]]. Businessweek<ref>Businessweek [http://investing.businessweek.com
    22 KB (2,962 words) - 12:56, 18 December 2017
  • ...nce includes serving as director of corporate affairs with [[Bristol-Myers Squibb]], Legislative Associate to the [[New York State Assembly]] Committee on Go
    3 KB (434 words) - 14:28, 10 January 2008
  • ...nce includes serving as director of corporate affairs with [[Bristol-Myers Squibb]], Legislative Associate to the [[New York State Assembly]] Committee on Go
    961 bytes (127 words) - 20:06, 2 January 2008
  • ...) and non-executive chairman of the Board of Directors for [[Bristol-Myers Squibb]] (since 1976). He also serves on the Boards of Directors of [[Novell Inc.]
    8 KB (1,182 words) - 15:10, 31 January 2008
  • [[Bristol Myers Squibb]]
    4 KB (463 words) - 17:22, 18 February 2008
  • ...l-Myers Squibb [http://www.b-ms.co.uk/info-for-patients2.htm Bristol-Myers Squibb and its financial relationship with patient groups and charitable organisat
    3 KB (402 words) - 15:00, 25 June 2015
  • * [[Bristol-Myers Squibb]]
    3 KB (286 words) - 15:30, 12 February 2008

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)